Skip to main content

Investor FAQs

On what stock exchange are Mirati Therapeutics, Inc. shares traded, and what is the ticker symbol? When was Mirati’s Initial Public Offering? Where is Mirati’s corporate headquarters? When does Mirati’s fiscal year end? Who are the Company’s independent registered public accountants? Who is Mirati’s legal counsel? Who is Mirati’s transfer agent? Does Mirati pay dividends? Does Mirati Therapeutics, Inc. have a direct stock purchase plan? Where can I find Mirati Therapeutics, Inc. securities filings? Where can I download and view quarterly and annual reports? How do I contact Investor Relations with a question or request?
On what stock exchange are Mirati Therapeutics, Inc. shares traded, and what is the ticker symbol?

The Mirati Therapeutics, Inc. ticker is MRTX and is traded on the NASDAQ.

back to top
When was Mirati’s Initial Public Offering?

In June 2013, Mirati Therapeutics, Inc. became the ultimate parent corporation of MethylGene Inc. and subsidiaries by a court - and shareholder-approved plan of agreement. Mirati shares began trading on the NASDAQ on July 15, 2013.

back to top
Where is Mirati’s corporate headquarters?

9393 Towne Centre Drive, Suite 200
San Diego, CA 92121

back to top
When does Mirati’s fiscal year end?

December 31st

back to top
Who are the Company’s independent registered public accountants?

Ernst & Young LLP

back to top
Who is Mirati’s legal counsel?

Cooley LLP

back to top
Who is Mirati’s transfer agent?

Computershare, Inc.

back to top
Does Mirati pay dividends?

Mirati Therapeutics, Inc. does not expect to declare or pay any cash or other dividends on our common stock, as we intend to reinvest cash flow generated by operations in our business.

back to top
Does Mirati Therapeutics, Inc. have a direct stock purchase plan?

Mirati Therapeutics, Inc. does not have a direct stock purchase plan.

back to top
Where can I find Mirati Therapeutics, Inc. securities filings? Where can I download and view quarterly and annual reports?

Quarterly and annual reports, as well as other SEC filings, can be accessed on the Financials & Filings portion of our Investor Relations website or directly from the SEC at http://www.sec.gov/. Note that in June 2013, Mirati Therapeutics, Inc. became the ultimate parent corporation of MethylGene Inc. and subsidiaries by a courtand shareholder-approved plan of arrangement.

back to top
How do I contact Investor Relations with a question or request?

You can contact Mirati Therapeutics, Inc. Investor Relations group via email at ir@mirati.com.

back to top